Purity assay comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-03-29. Where a claim depends on a specific study, the study is described rather than over-claimed.
Analytical verification commonly relies on high-performance liquid chromatography for purity assessment and mass spectrometry for identity confirmation. Spectroscopic methods such as UV-visible absorption and electron paramagnetic resonance can probe the metal centre itself, since the d9 configuration of copper(II) produces characteristic signals. Elemental analysis or plasma-based techniques quantify copper content. Because each method reports a different aspect of the same sample, purity figures are most meaningful when the technique and its detection wavelength are stated alongside the value.
Stability of the complex in solution depends on pH, temperature, and the presence of competing ligands. It is generally described as more resistant to breakdown than the metal-free chain, since coordination reduces susceptibility to enzymatic attack. Oxidation and hydrolysis can nevertheless proceed over time in aqueous media. Storage guidance in laboratory settings commonly involves refrigeration, protection from light, and avoidance of strongly alkaline conditions. Published data on long-term behaviour vary considerably and depend on the specific matrix.
Handling practices for the solid material emphasise low temperature and dryness. The lyophilised or powdered form is typically kept at refrigerator or freezer temperatures together with a desiccant. Working solutions are often prepared fresh, because repeated freeze-thaw cycles and extended storage may alter the complex. Glass or inert plastic containers are preferred over materials that could leach metal ions into the preparation. Such practices follow general peptide conventions rather than substance-specific regulations.
Published studies describe the complex in several research contexts, including collagen synthesis, antioxidant behaviour, and wound repair models. Much of this work is conducted in cultured cells or in small animal systems, and the findings are frequently cited in reviews of copper peptides. Direct clinical evidence in humans is comparatively limited, and reported outcomes vary with formulation and study design. Whether free chain or metal-bound form was used is not always stated, a point that complicates comparison between reports.
GHK-Cu is a coordination complex formed between the peptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The unbound chain, abbreviated GHK, consists of three amino acids and occurs naturally in human plasma, saliva, and urine. Binding of the metal is mediated mainly by the imidazole nitrogen of the histidine residue together with backbone amides, producing a stable chelate. Ingredient nomenclature often lists the same substance as copper tripeptide-1. Its charge and solubility behaviour differ from those of the metal-free chain.
The copper-binding activity of this sequence was described in the 1970s during studies of liver tissue and plasma factors. Early work identified the peptide as a component that influenced copper uptake by cells and that appeared in wound fluid. Later investigations examined its presence across species, reporting the same chain in human and animal samples. A decline in measured concentration with age became a recurring observation, although the underlying causes remain incompletely characterised.
| Property | Value | Notes |
|---|---|---|
| Appearance | Blue crystalline solid | Colour arises from copper(II) d-d transitions |
| Water solubility | Readily soluble | Extent varies with pH and counterion |
| Typical storage | Minus 20 degrees Celsius, desiccated | Protect from light and moisture |
| Purity method | Reverse-phase HPLC, UV detection | Wavelength typically 214 or 220 nanometres |
| Identity method | Mass spectrometry | Confirms peptide mass and copper content |
Dry material is normally held cold, commonly at -20 °C for long-term storage and 2 to 8 °C for working quantities, protected from light and moisture. Vials should be allowed to reach room temperature before opening so that condensation does not form on the powder. In liquid formulations the complex is generally kept near neutral to slightly acidic pH, because strongly alkaline conditions favour precipitation of copper hydroxide. Antioxidants or chelate-stabilising excipients are often added, though the specific approaches are proprietary and rarely published in detail.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry to confirm the expected mass. Copper content is measured separately by inductively coupled plasma optical emission spectrometry or atomic absorption spectroscopy, because the peptide assay alone does not establish the metal-to-peptide ratio. Visible spectroscopy provides a rapid check on complex integrity through the absorption band in the visible region. Agreement between the peptide assay and the copper assay is the practical test of whether a sample is the intended complex rather than a mixture.
Aqueous solutions of GHK-Cu are less stable than the dry powder. The peptide backbone is vulnerable to hydrolysis at extreme pH, and copper can be stripped from the complex by strong chelating agents such as EDTA or citrate. Oxidising agents and high concentrations of ascorbic acid can reduce copper(II) and change the complex, which is one reason formulators often keep such ingredients in separate phases. How quickly these changes occur under real storage conditions depends on pH, buffer, temperature and packaging, and quantitative data on the subject are limited.
The International Nomenclature of Cosmetic Ingredients lists the substance as copper tripeptide-1, the name that appears on most topical product labels. Related designations include copper peptide and GHK-Cu, and the hyphenated form is common in research literature. In cosmetics the material is regulated as an ingredient rather than as a drug, so products may reach the market without evidence of the effects claimed for them. Whether those effects are clinically meaningful is an open question, since most supportive data come from laboratory work and small trials.
GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine, a short sequence found naturally in human plasma, saliva and urine. Loren Pickart reported the isolation of the free peptide in 1973 while studying factors that influenced the growth of aged liver cells in culture. The peptide was later shown to bind copper(II) with high affinity, and the metal-bound form became the focus of most subsequent research. Its concentration in circulation declines markedly with age, a pattern that is well documented, though the physiological consequences of that decline remain debated.
Identity and purity are commonly assessed by reversed-phase high-performance liquid chromatography, frequently paired with mass spectrometry to confirm the molecular ion. Copper content is measured separately, typically by inductively coupled plasma mass spectrometry or atomic absorption spectroscopy, because the chromatographic signal reports the peptide rather than the metal. Ultraviolet-visible spectroscopy provides a fast check on complex formation, since copper(II) peptide complexes absorb in the visible region. Elemental analysis and amino acid analysis are used less often but remain useful for reference standards. A gap between reported peptide purity and measured copper content is a recurring source of confusion.
Material described as GHK-Cu appears in several distinct markets, including cosmetic ingredients, laboratory reagents, and consumer products, and the quality expectations attached to each differ. A certificate of analysis generally reports peptide purity by chromatography, copper content, appearance, and residual solvents or counterions. Counterion identity matters, because the complex is usually supplied as an acetate or a similar salt, and the counterion contributes to the measured mass. Independent verification of sequence and metal stoichiometry is advisable when a material is used for quantitative work. Batch-to-batch variation is common and should be documented rather than assumed negligible.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-lysine and a copper(II) ion. The peptide sequence is conventionally written as Gly-His-Lys, abbreviated GHK. Copper binds through the imidazole nitrogen of histidine, the alpha-amino group, and a deprotonated amide nitrogen, producing a square-planar geometry. The complex carries a net positive charge near physiological pH and is intensely blue in aqueous solution. The metal-free peptide is often written simply as GHK, while the copper-bound form is written GHK-Cu.
The compound was first isolated from human plasma by the biochemist Loren Pickart in 1973. Early work identified it as a factor that altered the behavior of cultured liver cells, and later studies linked it to connective tissue and wound-related processes. Reported plasma concentrations fall markedly between roughly age twenty and age sixty, a pattern that generated interest in copper peptide biology. Whether that decline has functional consequences remains an open question, because differences observed across age groups do not by themselves establish causation. Research interest later expanded into cosmetic and tissue-culture settings.
== History == Frederick William Hope coined the term myiasis in 1840 to refer to diseases resulting from dipterous larvae as opposed to those caused by other insect larvae (the term for this was scholechiasis). Hope described several cases of myiasis from Jamaica caused by unknown larvae, one of which resulted in death. Even though the term myiasis was first used in 1840, such conditions have been known since ancient times. Ambroise Paré, the chief surgeon to King Charles IX and King Henry III, observed that maggots often infested open wounds.
=== Prevention === Prevention relies on a farm to plate approach involving the whole supply chain anchored in risk analysis and good hygiene practices. Internationally, the Codex Alimentarius General Principles of Food Hygiene provide the foundation for national food safety systems and industry controls. These guidelines are then implemented through various prerequisite programs and HACCP (Hazard Analysis and Critical Control Point) which identify, monitor, and control hazards at specific steps in production. For consumers and food service businesses, evidence-based guidance involves four key steps: Clean, Separate, Cook, Chill. These techniques reduce cross-contamination and ensure lethal heat treatment and rapid refrigeration. Since supply chains are complex, it is critical to prioritize monitoring high-risk foods, such as minimally processed fresh produce, and modifying controls such as, agricultural water safety, manure management, worker hygiene, and post-harvest sanitation. Overall, strengthening surveillance and rapid information-sharing through a One Health lens by linking human, animal, and environmental data, improves outbreak detection and targeted interventions. This is a priority of the WHO Global Strategy for Food Safety 2022–2030.
Tofu has also been fused into other cuisines in the West, for instance in Indian-style curries. Tofu and soy protein can be industrially processed to match the textures and flavors of cheese, pudding, eggs, bacon, and similar products. Tofu's texture can also be altered by freezing, puréeing, and cooking. In the Americas, Europe, Australia and New Zealand, tofu is frequently associated with vegetarianism and veganism, as it is a source of non-animal protein. In India, tofu is used as a low-fat replacement for paneer, providing a similar texture. Awara (also known as wara soya, Nigerian tofu, or Beske), is a food commonly consumed in Northern Nigeria. It's produced by curdling soy milk with a natural agent, then pressing, seasoning, and frying it into cubes. As opposed to an ingredient substitute, the tofu is eaten as the main ingredient, often with vegetables on the side.
=== Pittsburgh Pirates (1960–62) === Mizell's trade to the Pirates was one of the catalysts of Pittsburgh's championship run that season. Facing the Giants on June 16, 1960, he threw 166 pitches and stayed in the ballgame for three hours and two minutes, allowing two runs through eight innings before allowing three hits to start the ninth and getting charged with three more runs, though he still earned the win in the 10–7 victory. "Shucks, no. I wasn't tired," he quipped after the game. On the strength of two shutouts, he pitched 30 consecutive scoreless innings from July 22 to August 9, the longest such streak of his career. The first shutout may have been his best game of the season; he held the Cubs to two hits in a 4–0 victory on July 29. Six days later, he allowed five hits but no runs to the Giants, securing a 1–0 triumph. On September 18, he won another 1–0 game, limiting Cincinnati to three hits in nine innings. In the month of September, he had a 5–1 record and a 3.14 ERA as the Pirates clinched the NL pennant. Mizell went 13-5 for the Pirates that season (14–8 overall) and finished sixth in the NL in winning percentage (.636). Between St. Louis and Pittsburgh, he had a 3.50 ERA (3.12 with the Pirates), striking out 113 and walking 74 in 211 innings. Of the walks, 10 were intentional. Mizell started Game 3 of the 1960 World Series against the New York Yankees but was removed in the first inning, having given up three hits and a walk while only retiring one hitter. He was charged with the loss as the Yankees won 10–0.
There are numerous associations and correlations in the body of evidence, but few causal relationships, since existing longitudinal datasets "do not use consistent wellbeing and predictor measures at different time points"; After controlling for mental health status, not many of the found associations are still significant; Subgroup analyses are rare; There are too few studies to conduct meta-analyses; There are too few interventional studies.
Sources: en.wikipedia.org
== Usage == AUFS is an arbitrary unit of the maximum ultraviolet or visible light absorbance intensity measured by a detector. It can be used in chemical analysis to quantify components in a mixture, as each component's integrated peak area corresponds to their relative abundance. AUFS is given as a number ranging from 0 to 1, where a measurement of 1 AUFS indicates an absorbance reading of 1 at full deflection.
=== Medicine === Medical technicians may sequence genes (or, theoretically, full genomes) from patients to determine if there is risk of genetic diseases. This is a form of genetic testing, though not all genetic tests involve complete genome DNA sequencing. As of 2013 DNA sequencing was increasingly used to diagnose and treat rare diseases. As more and more genes are identified that cause rare genetic diseases, molecular diagnoses for patients become more mainstream. DNA sequencing allows clinicians to identify genetic diseases, improve disease management, provide reproductive counseling, and more effective therapies. Gene sequencing panels are used to identify multiple potential genetic causes of a suspected disorder. Also, DNA sequencing may be useful for determining a specific bacteria, to allow for more precise antibiotics treatments, hereby reducing the risk of creating antimicrobial resistance in bacteria populations.
Although his physical endurance is immense, Neo can still be harmed or killed, as evidenced by an injury that Neo suffers while blocking a sword attack with his bare hand. His endurance is also finite: when confronted by masses of Smith clones in the second film, Neo was forced to escape rather than continue fighting though he easily overpowered at least 40 Smith clones and threw about 50 off him, and upon being disconnected from the Matrix, he appeared exhausted and winded. His reflexes are great enough to dodge bullets. Neo's strength and speed level have never been accurately measured; he is known to be capable of Mach 8, at least, and Mach 10 under stress, but his upper limit has never been shown. In the third movie, Neo has reached his (apparent) full strength; he is capable of withstanding a direct physical punch from the Smith enhanced by the Oracle's power, and is also able to hold his own in a prolonged fight (though his endurance is not without limit; he can fight this Smith to a standstill, but not defeat him). In the real world, like the other rebels, Neo does not display any of the aforementioned abilities. According to the Oracle, "The power of The One extends beyond the Matrix.
=== Cleansing === Cleansing is the process of removing dirt, oil, makeup, and other impurities from the skin. Lathering cleansers, a common type of facial cleanser, generate lather when used, thanks to a surfactant level greater than the CMC (critical micelle concentration). These cleansers contain surfactants with short hydrophobic chains, enabling faster and higher levels of lather. Most lathering cleansers on the market use synthetic surfactants designed to be mild to the skin, reducing skin damage compared to naturally derived surfactants. However, they may be less effective at removing oil-soluble makeup. Liquid lathering cleansers clean through the chemical process of emulsification, suspending or emulsifying dirt and oils, thus allowing them to be removed from the skin during the rinse process. Exfoliating cleansers are used to cleanse and exfoliate the skin twice per day, in the morning and evening. There also exist soapless or "no-rinse" cleansers (syndets).
Sources: en.wikipedia.org
Reverse-phase high-performance liquid chromatography with ultraviolet detection is the most common approach. Purity is expressed as a share of total peak area at a specified wavelength. Mass spectrometry is then used to confirm molecular identity.
Solid material is often held at refrigerator or freezer temperatures, typically between minus 20 and 4 degrees Celsius. Desiccation limits moisture uptake. Solution stability is generally shorter and varies with pH and buffer composition.
Electron paramagnetic resonance is suited to copper(II) because of its unpaired electron. UV-visible spectroscopy reveals ligand-to-metal charge transfer bands. Both methods report on coordination rather than on peptide purity.
GHK denotes the unbound chain of three amino acids. GHK-Cu describes the form in which a copper(II) ion is held by that chain. The two are not interchangeable in solution, since charge, molecular weight, and reactivity differ.